PT971585E - Compostos tetraciclina no tratamento de certos tipos de cancros - Google Patents
Compostos tetraciclina no tratamento de certos tipos de cancrosInfo
- Publication number
- PT971585E PT971585E PT98902437T PT98902437T PT971585E PT 971585 E PT971585 E PT 971585E PT 98902437 T PT98902437 T PT 98902437T PT 98902437 T PT98902437 T PT 98902437T PT 971585 E PT971585 E PT 971585E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- cells
- growth
- tetracycline compounds
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/783,655 US5837696A (en) | 1997-01-15 | 1997-01-15 | Method of inhibiting cancer growth |
Publications (1)
Publication Number | Publication Date |
---|---|
PT971585E true PT971585E (pt) | 2006-08-31 |
Family
ID=25130005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98902437T PT971585E (pt) | 1997-01-15 | 1998-01-15 | Compostos tetraciclina no tratamento de certos tipos de cancros |
Country Status (11)
Country | Link |
---|---|
US (2) | US5837696A (pt) |
EP (1) | EP0971585B1 (pt) |
JP (1) | JP4428727B2 (pt) |
KR (1) | KR20000070212A (pt) |
AT (1) | ATE321452T1 (pt) |
AU (1) | AU729886B2 (pt) |
CA (1) | CA2277865C (pt) |
DE (1) | DE69834024T2 (pt) |
ES (1) | ES2262221T3 (pt) |
PT (1) | PT971585E (pt) |
WO (1) | WO1998031224A1 (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837696A (en) * | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
US6429204B1 (en) | 1997-01-15 | 2002-08-06 | University Of Miami | Method of inhibiting cancer growth |
US6319910B1 (en) * | 1997-12-19 | 2001-11-20 | Hospital For Joint Diseases | Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
US6277061B1 (en) | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5977091A (en) * | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
EP1140183A1 (en) * | 1998-12-23 | 2001-10-10 | G.D. Searle & Co. | Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
US6984619B1 (en) * | 1999-03-19 | 2006-01-10 | Arch Development Corporation | Method for protection against tumor metastasis formation |
DE10032256C2 (de) * | 2000-07-03 | 2003-06-05 | Infineon Technologies Ag | Chip-ID-Register-Anordnung |
NZ529308A (en) * | 2001-04-05 | 2005-03-24 | Collagenex Pharm Inc | Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity |
US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
EP2332546A1 (en) | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
WO2003030819A2 (en) * | 2001-10-05 | 2003-04-17 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives and methods of use thereof |
PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
JP2005514410A (ja) | 2002-01-08 | 2005-05-19 | パラテック ファーマシューティカルズ インコーポレイテッド | 4−デジメチルアミノテトラサイクリン化合物 |
CA2478335C (en) | 2002-03-08 | 2011-05-10 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
AU2003218243B2 (en) | 2002-03-21 | 2010-04-01 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
US20050153943A1 (en) * | 2002-05-06 | 2005-07-14 | Ashley Robert A. | Methods of simultaneously treating mucositis and fungal infection |
JP2005533766A (ja) * | 2002-05-20 | 2005-11-10 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | アレルギー反応の治療方法 |
KR101089429B1 (ko) | 2002-07-12 | 2011-12-07 | 파라테크 파마슈티컬스, 인크. | 3, 10, 및 12a 치환된 테트라시클린 화합물 |
WO2004038000A2 (en) * | 2002-10-24 | 2004-05-06 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate rna |
PT1615622E (pt) | 2003-04-07 | 2012-10-17 | Supernus Pharmaceuticals Inc | Formulações de doxiciclinas de dose única diária |
EA200600221A1 (ru) | 2003-07-09 | 2006-06-30 | Пэрэтек Фамэсьютикэлс, Инк. | Замещённые соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта |
JP4738333B2 (ja) | 2003-07-09 | 2011-08-03 | パラテック ファーマシューティカルズ インコーポレイテッド | 9−アミノメチルテトラサイクリン化合物のプロドラッグ |
WO2005070878A1 (en) * | 2004-01-15 | 2005-08-04 | Paratek Pharmaceuticals, Inc. | Aromatic a-ring derivatives of tetracycline compounds |
EP2033950A1 (en) | 2004-10-25 | 2009-03-11 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
EP2301916A3 (en) | 2004-10-25 | 2011-09-28 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
JP2009502809A (ja) * | 2005-07-21 | 2009-01-29 | パラテック ファーマシューティカルズ インコーポレイテッド | 10−置換テトラサイクリンおよびその使用方法 |
WO2008079363A2 (en) * | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
EP3812372A3 (en) | 2006-12-21 | 2021-06-30 | Paratek Pharmaceuticals, Inc. | 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases |
JP2010525069A (ja) * | 2007-04-27 | 2010-07-22 | パラテック ファーマシューティカルズ インコーポレイテッド | アミノアルキルテトラサイクリン化合物の合成方法および精製方法 |
DK2176216T3 (da) * | 2007-07-06 | 2012-07-30 | Paratek Pharm Innc | Fremgangsmåder til syntetisering af 9-substitueret minocyclin |
TW202332671A (zh) | 2008-05-23 | 2023-08-16 | 美商Prtk Spv2公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
CA2732883C (en) | 2008-08-08 | 2018-03-06 | Tetraphase Pharmaceuticals, Inc. | C7-fluoro substituted tetracycline compounds |
WO2010129057A2 (en) | 2009-05-08 | 2010-11-11 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
WO2011025982A2 (en) | 2009-08-28 | 2011-03-03 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
CA2790240A1 (en) * | 2010-03-10 | 2011-09-15 | University Health Network | Use of tigecycline for treatment of cancer |
EP2552890B1 (en) | 2010-03-31 | 2017-01-04 | Tetraphase Pharmaceuticals, Inc. | Polycyclic tetracycline compounds |
SI2890673T1 (sl) | 2012-08-31 | 2019-05-31 | Tetraphase Pharmaceuticals, Inc. | Spojine tetraciklina |
JP6513576B2 (ja) | 2013-01-14 | 2019-05-15 | ヘルス クリニックス リミテッド | 抗がん剤および使用 |
US10961190B2 (en) | 2016-10-19 | 2021-03-30 | Tetraphase Pharmaceuticals, Inc. | Crystalline forms of eravacycline |
US11229657B2 (en) | 2017-04-21 | 2022-01-25 | Lunella Biotech, Inc. | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy |
WO2018195434A1 (en) | 2017-04-21 | 2018-10-25 | Lisanti Michael P | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
US12006553B2 (en) | 2017-05-19 | 2024-06-11 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
RU2019142102A (ru) | 2017-05-19 | 2021-06-21 | Лунелла Байотек, Инк. | Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток |
US20210395198A1 (en) | 2018-11-09 | 2021-12-23 | Tetraphase Pharmaceuticals, Inc. | Polymorphic forms of a compound and uses thereof |
CN115006411A (zh) * | 2022-07-26 | 2022-09-06 | 中南大学湘雅医院 | 依拉环素类化合物的应用、药物及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
JP3016587B2 (ja) * | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
AU1411992A (en) * | 1991-01-15 | 1992-08-27 | Robert A Bok | A composition containing a tetracycline and use for inhibiting angiogenesis |
US5668122A (en) * | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
US5574026A (en) * | 1994-12-13 | 1996-11-12 | American Cyanamid Company | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth |
US5567693A (en) * | 1994-12-13 | 1996-10-22 | American Cyanamid Company | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US5563130A (en) * | 1994-12-13 | 1996-10-08 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US5837696A (en) * | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
-
1997
- 1997-01-15 US US08/783,655 patent/US5837696A/en not_active Expired - Lifetime
-
1998
- 1998-01-15 AT AT98902437T patent/ATE321452T1/de active
- 1998-01-15 KR KR1019997006438A patent/KR20000070212A/ko not_active Application Discontinuation
- 1998-01-15 WO PCT/US1998/000332 patent/WO1998031224A1/en active IP Right Grant
- 1998-01-15 DE DE69834024T patent/DE69834024T2/de not_active Expired - Lifetime
- 1998-01-15 JP JP53443498A patent/JP4428727B2/ja not_active Expired - Fee Related
- 1998-01-15 EP EP98902437A patent/EP0971585B1/en not_active Expired - Lifetime
- 1998-01-15 PT PT98902437T patent/PT971585E/pt unknown
- 1998-01-15 AU AU59104/98A patent/AU729886B2/en not_active Ceased
- 1998-01-15 CA CA002277865A patent/CA2277865C/en not_active Expired - Fee Related
- 1998-01-15 US US09/007,645 patent/US6100248A/en not_active Expired - Lifetime
- 1998-01-15 ES ES98902437T patent/ES2262221T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE321452T1 (de) | 2006-04-15 |
EP0971585A1 (en) | 2000-01-19 |
JP4428727B2 (ja) | 2010-03-10 |
KR20000070212A (ko) | 2000-11-25 |
US6100248A (en) | 2000-08-08 |
AU5910498A (en) | 1998-08-07 |
EP0971585A4 (en) | 2001-01-24 |
EP0971585B1 (en) | 2006-03-29 |
US5837696A (en) | 1998-11-17 |
CA2277865C (en) | 2009-06-02 |
CA2277865A1 (en) | 1998-07-23 |
WO1998031224A1 (en) | 1998-07-23 |
JP2001508794A (ja) | 2001-07-03 |
DE69834024D1 (de) | 2006-05-18 |
AU729886B2 (en) | 2001-02-15 |
ES2262221T3 (es) | 2006-11-16 |
DE69834024T2 (de) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT971585E (pt) | Compostos tetraciclina no tratamento de certos tipos de cancros | |
MX9804009A (es) | Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8. | |
DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
YU596A (sh) | Estrogen agonisti/antagonisti | |
EP1019060A4 (en) | ANDROGENSYNTHESEINHIBITOREN | |
DE60040981D1 (de) | BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN | |
DK1214292T3 (da) | Tyrosinderivater | |
ZA988826B (en) | Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation | |
YU21401A (sh) | Tetrahidropiridoetri | |
MY122020A (en) | Use of gabab receptor agonists as reflux inhibitors | |
TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
BR9912327A (pt) | Inibidores da uroquinase | |
TR200002921T2 (tr) | Yarı-Sentetik ekteinasidinler | |
HUP0104688A2 (hu) | Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez | |
BR0008788A (pt) | Sequencias anti-sentido antitumor dirigidas contra componentes r1 e r2 de ribonucleotìdeo reductase | |
AU3052799A (en) | Pharmaceutical compositions comprising erythropoietin for treatment of cancer | |
GB0215526D0 (en) | Anticancer compounds | |
MX9700624A (es) | Azolidinonas de imidazopiridina. | |
IL189502A0 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
MXPA02007173A (es) | Compuestos calciliticos. | |
EP1383511A4 (en) | CALCILYTIC COMPOUNDS | |
IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds | |
CA2294243A1 (en) | Novel cyanoaziridines for treating cancer | |
MXPA02008014A (es) | Composiciones inhibidoras de tumores de 1-nitroacridina. |